Flag­ship com­pa­ny teams up with Charles Riv­er for AI drug dis­cov­ery

One of Flag­ship’s en­ti­ties will be get­ting ac­cess to an AI drug dis­cov­ery tool from con­tract de­vel­op­er and man­u­fac­tur­er Charles Riv­er Lab­o­ra­to­ries.

On Thurs­day, Charles Riv­er an­nounced that Pi­o­neer­ing Med­i­cines, a unit of Flag­ship Pi­o­neer­ing, is seek­ing its ser­vices. The deal will see Pi­o­neer­ing Med­i­cines have ac­cess to Charles Riv­er’s and Va­lo Health’s AI drug dis­cov­ery plat­form, Log­i­ca. Pi­o­neer­ing Med­i­cines plans to use the plat­form across sev­er­al tar­gets to find and cre­ate small mol­e­cules that can be even­tu­al­ly turned in­to new ther­a­pies.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER